ERBB2 and breast cancer: One hundred ninety-six women aged over 60 years with early-stage hormone receptor-positive HER2-enriched BC patients who received cryoablation followed by endocrine therapy had an ipsilateral breast tumor recurrence rate of 3.7% at 5 years, compared to an IBTR rate of 4.